PlaqueTec vs Ray Therapeutics
PlaqueTec vs Ray Therapeutics, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: PlaqueTec is on 34/100 and Ray Therapeutics on 53/100.
Where each one leads
PlaqueTec
- agent readiness: 44/100 against 21/100
Ray Therapeutics
- our overall score: 53/100 against 34/100
- domain rating: 29/100 against 16/100
- funding raised: $243M against $5.0M
At a glance
| Measure | PlaqueTec | Ray Therapeutics |
|---|---|---|
| What it is | Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease. | Pioneering vision restoration therapies for severe retinal degenerations. |
| Category | Biotechnology, Medical Devices, HealthTech, Artificial Intelligence | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | Not published | 2021 |
| Headquarters | Cambridge, United Kingdom | Berkeley, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | PlaqueTec | Ray Therapeutics |
|---|---|---|
| Total funding | $5.0M | $243M |
| Latest round | Funding Round | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | PlaqueTec | Ray Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 34/100 | 53/100 |
| Traction | 33/100 | 40/100 |
| Team | Not published | 50/100 |
| Search visibility | 15/100 | 14/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 16/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | PlaqueTec | Ray Therapeutics |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Wix | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Analytics 4 |
| Open source | Yes | No |
PlaqueTec vs Ray Therapeutics: common questions
Which is better, PlaqueTec or Ray Therapeutics?
On our 0-100 score Ray Therapeutics rates higher (53/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do PlaqueTec and Ray Therapeutics compare on the numbers?
PlaqueTec leads on agent readiness (44/100 against 21/100). Ray Therapeutics leads on our overall score (53/100 against 34/100), domain rating (29/100 against 16/100), funding raised ($243M against $5.0M).
Read the full PlaqueTec review and pricing or the Ray Therapeutics review and pricing. You can also browse other PlaqueTec alternatives we track.